GlassScriptPhysician profile
Daniel Loring Elgut
NPI 1215354352
$72,571.28
in general payments reported to CMS, 2019-2025
40 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $32K · 2021: $14K · 2022: $4,488 · 2023: $4,067 · 2024: $1,563 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,179 · Consulting Fee: $2,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,179.14 |
| Consulting Fee | $2,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $43,217.21 | 2019-2022 | |
| Avitus Orthopaedics, INC. | $6,840.00 | 2020-2021 | |
| In2bones USA, LLC | $6,549.46 | 2020-2022 | |
| Bone Support INC. | $4,413.36 | 2021-2023 | Ceramentbone Void Filler |
| Stryker Corporation | $3,483.82 | 2019-2025 | Variax, Prostep, Anchorage |
| Linvatec Corporation | $1,950.57 | 2022-2024 | Colink Plating System, Biobrace 23mm, 5ms |
| Integra Lifesciences Corporation | $1,844.68 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Horizon Therapeutics Plc | $763.18 | 2019-2022 | |
| Treace Medical Concepts, INC. | $613.95 | 2022-2025 | |
| Biocomposites INC | $438.37 | 2025 | Stimulan |
| Wright Medical Technology, INC. | $356.49 | 2019-2020 | |
| Fusion Orthopedics USA, LLC | $306.18 | 2024-2025 | |
| Djo, LLC | $202.65 | 2021-2024 | Cmf, Chattanooga |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $162.98 | 2022-2023 | Jublia |
| Smith+Nephew, INC. | $152.13 | 2019-2024 | Collagenase Santyl, Regranex |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Embody, INC. | $139.91 | 2021-2022 | |
| Southern Edge Orthopaedics, INC. | $113.55 | 2025 | |
| Medartis INC. | $110.06 | 2022 | |
| Cardiovascular Systems INC. | $93.27 | 2019 | |
| Depuy Synthes Sales INC. | $83.00 | 2021 | |
| Maxx Health INC | $78.52 | 2023 | Summa Ortho Cannulated Screw, Summa Ortho Optossol, Summa Ortho Foot |
| Globus Medical, INC. | $66.61 | 2024 | Allocate |
| Trimed, INC. | $63.05 | 2020 | |
| Orthofix Medical, INC. | $52.78 | 2019-2022 | |
| Melinta Therapeutics, LLC | $52.33 | 2019 | |
| Organogenesis INC. | $49.34 | 2024 | |
| Vilex LLC | $48.91 | 2024 | |
| Bioventus LLC | $43.63 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $42.34 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sebela Pharmaceuticals INC. | $38.68 | 2019-2022 | |
| Acera Surgical, INC. | $26.86 | 2022 | |
| Medshape, INC. | $26.32 | 2022 | |
| Ossio INC | $25.63 | 2021 | |
| Anika Therapeutics, INC. | $19.89 | 2022 | |
| Bard Peripheral Vascular, INC. | $19.13 | 2020 | |
| Amgen INC. | $18.17 | 2025 | Krystexxa |
| Mimedx Group, INC. | $18.12 | 2024 | |
| Merck Sharp & Dohme LLC | $16.47 | 2019 | |
| Acell, INC. | $14.87 | 2019 | |
| Lifenet Health | $14.81 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Elgut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.